Cart
sales@molnova.com
GSK1940029
CAS No. 1150701-66-8
GSK1940029( SCD inhibitor 1 )
Catalog No. M20222 CAS No. 1150701-66-8
GSK1940029 is a stearoyl-coa desaturase (SCD) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 237 | In Stock |
|
| 10MG | 357 | In Stock |
|
| 25MG | 597 | In Stock |
|
| 50MG | 851 | In Stock |
|
| 100MG | 1152 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK1940029
-
NoteResearch use only not for human use.
-
Brief DescriptionGSK1940029 is a stearoyl-coa desaturase (SCD) inhibitor.
-
DescriptionGSK1940029 is a stearoyl-coa desaturase (SCD) inhibitor.
-
SynonymsSCD inhibitor 1
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorSCD
-
Research AreaEndocrinology
-
IndicationAcne Vulgaris
Chemical Information
-
CAS Number1150701-66-8
-
Formula Weight391.25
-
Molecular FormulaC18H16Cl2N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:30 mg/mL (76.67 mM)
-
SMILESCc1c(nnn1Cc1ccc(Cl)c(Cl)c1)C(=O)Nc1ccc(CO)cc1
-
Chemical Name1-[(34-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyltriazole-4-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Anne Marie Jeanne Bouillot et al. 1 2 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors . PCT Int. Appl. (2009) WO 2009060053 A1 20090514.
molnova catalog
related products
-
MF-438
MF-438 is an effective and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhibitor (EC50: 2.3 nM for rSCD1). In a mouse model, MF-438 shows an ED50 between 1 and 3 mg/kg.
-
Glycyrrhizin
Actions Biologically active constituent in the sweet root of Glycyrrhiza species (licorice). Antiviral.
-
Tenuifoliside B
Tenuifoliside B is a natural?product from? the roots of Polygala tenuifolia.And is?a target lactate dehydrogenase inhibitor.?Tenuifoliside B has cognitive improving and cerebral protective effects.?it can inhibit potassium cyanide (KCN)-induced hypoxia and scopolamine-induced memory impairment in mice.
